Explore Shanghai RAAS Blood Products's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.
| Metric | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Revenue(millions of USD) | 1,050a CN¥7,348 million | 1,120a CN¥8,176 million | 1,121a CN¥7,964 million |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.